Cover [Abstract]
Entity Registrant Name
Entity Central Index Key
Document Type
Amendment Flag
Entity Voluntary Filers
Current Fiscal Year End Date
Entity Well Known Seasoned Issuer
Entity Small Business
Entity Shell Company
Entity Emerging Growth Company
Entity Current Reporting Status
Document Period End Date
Entity Filer Category
Document Fiscal Period Focus
Document Fiscal Year Focus
Entity Common Stock Shares Outstanding
Entity Public Float
Document Annual Report
Document Transition Report
Document Fin Stmt Error Correction Flag
Entity File Number
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Address Address Line 1
Entity Address Address Line 2
Entity Address City Or Town
Entity Address State Or Province
Entity Address Postal Zip Code
City Area Code
Icfr Auditor Attestation Flag
Auditor Name
Auditor Location
Auditor Firm Id
Local Phone Number
Security 12g Title
Entity Interactive Data Current
CONSOLIDATED BALANCE SHEETS
Current assets:
Cash and cash equivalents
Investment securities
Trade accounts receivable, less allowance for doubtful accounts of $8,300 and $15,600 at December 31, 2025 and 2024, respectively
Inventories
[Inventory, Net]
Income tax receivable
Prepaid expenses and other current assets
Current assets of discontinued operations
Total current assets
[Assets, Current]
Property and equipment, net
Goodwill
Other intangible assets, net
Inventories
[Inventory, Noncurrent]
Operating lease right-of-use assets
Other assets
Other assets of discontinued operations
Total assets
[Assets]
Current liabilities:
Accounts payable
Accrued expenses
Contract liabilities
Lease liabilities, current portion
Current liabilities of discontinued operations
Total current liabilities
[Liabilities, Current]
Lease liabilities, less current portion
Total liabilities
[Liabilities]
Commitments and contingencies (Note 8)
Shareholders' equity:
Common stock, $0.05 par value; 30,000,000, shares authorized; 11,928,599 and 10,503,599, shares issued and outstanding at December 31, 2025 and 2024
Additional paid-in capital
Accumulated comprehensive income (loss)
Accumulated deficit
Total shareholders' equity
[Equity, Attributable to Parent]
Total liabilities and shareholders' equity
[Liabilities and Equity]
Allowance doubtful accounts
Shareholders' equity:
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Revenues
Cost of revenues
Gross profit
[Gross Profit]
Operating expenses:
General and administrative
Selling
Research and development
Impairment of intangible assets
Total operating expenses
[Operating Expenses]
Loss from operations
[Operating Income (Loss)]
Other income:
Other income, net
Gain on disposition of discontinued operations
Interest income
Total other income, net
[Nonoperating Income (Expense)]
Loss from continuing operations before income tax expense
[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]
Income tax expense, current
[Current Income Tax Expense (Benefit)]
Total income tax expense
[Income Tax Expense (Benefit)]
Loss from continuing operations
[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]
Discontinued operations:
Income from discontinued operations, net of tax
Net loss
[Net Income (Loss) Attributable to Parent]
Other comprehensive gain (loss):
Foreign currency translation gain (loss)
Other comprehensive gain (loss)
[Other Comprehensive Income (Loss), Net of Tax]
Total comprehensive loss
[Comprehensive Income (Loss), Net of Tax, Attributable to Parent]
Basic and Diluted gain (loss) per common share
Continuing operations
Discontinued operations
Consolidated operations
Weighted Average Shares Outstanding
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLERS EQUITY
Statement [Table]
Statement [Line Items]
Equity Components [Axis]
Additional Paid-In Capital
Common Stock
Retained Earnings (Accumulated Deficit)
Accumulated other comprehensive loss
Balance, shares
[Shares, Issued]
Balance, amount
Loss from Continuing Operations
Income from discontinued operations
Issuance of Common Stock and Warrants, net of issuance costs (Note 12), shares
Issuance of Common Stock and Warrants, net of issuance costs (Note 12), amount
Fair value modification of warrants recorded as stock issuance costs
Foreign currency translation adjustment
Stock-based compensation
Balance, shares
Balance, amount
CONSOLIDATED STATEMENTS OF CASH FLOWS
Operating activities:
Net loss
Less: Income from discontinued operations, net of tax
[Less: Income from discontinued operations, net of tax]
Loss from continuing operations
[Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent]
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on disposition of discontinued operations
Provision for bad debt
Provision for inventory reserves
Depreciation and amortization
Impairment of Intangible Assets
Stock-based compensation
[Share-Based Payment Arrangement, Noncash Expense]
(Gain) loss on sale of investment securities
[Gain (Loss) on Sale of Investments]
Unrealized holding loss (gain) on investment securities
[Unrealized Gain (Loss) on Investments]
Noncash lease expense
Changes in operating assets and liabilities:
Trade accounts receivable
[Increase (Decrease) in Accounts Receivable]
Inventories
[Increase (Decrease) in Inventories]
Prepaid expense and other current assets
[Increase (Decrease) in Prepaid Expense and Other Assets]
Income tax receivable
[Increase (Decrease) in Income Taxes Receivable]
Other assets
[Increase (Decrease) in Other Operating Assets]
Accounts payable
[Increase (Decrease) in Accounts Payable]
Accrued expenses
[Increase (Decrease) in Accrued Liabilities]
Contract liabilities
[Increase (Decrease) in Contract with Customer, Liability]
Lease liabilities
Net cash used in operating activities
[Cash Provided by (Used in) Operating Activity, Continuing Operation]
Investing activities:
Redemption of investment securities
Purchase of investment securities
[Payments to Acquire Investments]
Proceeds from disposition of discontinued operations
Capital expenditures
[Payments to Acquire Property, Plant, and Equipment]
Net cash provided by investing activities
[Cash Provided by (Used in) Investing Activity, Including Discontinued Operation]
Financing activities:
Proceeds from issuance of common stock
Issuance cost of common stock and warrants
[Payments of Stock Issuance Costs]
Net cash provided by financing activities
[Cash Provided by (Used in) Financing Activity, Including Discontinued Operation]
Discontinued Operations:
Net cash provided by (used in) operating activities of discontinued operations
Net change in cash
[Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation]
Effect of changes in foreign currency exchange rates on cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash from discontinued operations beginning of year
Less cash from discontinued operations end of year
Cash and cash equivalents, end of year
SUPPLEMENTAL DISCLOSURES:
Noncash financing activities:
Record right-of-use assets
Record lease liabilities
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted [Flag]
Rule 10b5-1 Arrangement Terminated [Flag]
Non Rule 10b5-1 Arrangement Adopted [Flag]
Non Rule 10b5-1 Arrangement Terminated [Flag]
Nature of the Business and Basis of Presentation
Nature of the Business and Basis of Presentation
Business Description and Basis of Presentation [Text Block]
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Fair Value Disclosures [Text Block]
Inventories
Inventories
Inventory Disclosure [Text Block]
Property and Equipment Net
Property and Equipment, Net
Goodwill and Finite Lived Intangible Assets
Goodwill and Finite Lived Intangible Assets
Goodwill Disclosure [Text Block]
Lines of Credit
Lines of Credit
Debt Disclosure [Text Block]
Commitments and Contingencies
Related Parties
Related Parties
Related Party Transactions Disclosure [Text Block]
Leases
Leases
Leases of Lessee Disclosure [Text Block]
Loss Per Common Share
Loss Per Common Share
Earnings Per Share [Text Block]
Common Stock and Warrants
Common Stock and Warrants
Equity [Text Block]
Stock Options
Stock Options
Share-Based Payment Arrangement [Text Block]
Segment Information
Segment Information
Segment Reporting Disclosure [Text Block]
Employee Benefit Plans
Employee Benefit Plans
Compensation and Employee Benefit Plans [Text Block]
Income Taxes
Income Taxes
Income Tax Disclosure [Text Block]
Discontinued Operations
Discontinued Operations
[Discontinued Operations]
Use of Estimates
Revenue Recognition
Segment Reporting
Cash and Cash Equivalents
Allowance for Credit Losses - Accounts Receivable
Investment Securities
Inventories
Inventory, Policy [Policy Text Block]
Property and Equipment
Goodwill and Finite Lived Intangible Assets and Long-Lived Assets, Net
Impairment of Long-Lived Assets
Leases
Lessee, Leases [Policy Text Block]
Advertising
Research and Development
Stock Compensation Plan
Foreign Currency Translation and Transactions
Income taxes
Earnings (Loss) Per Common Share
Reclassification
Recent Accounting Pronouncements not yet adopted
Schedule of fair value on a recurring basis
Investments in marketable securitites
Schedule of reconciliation of assets measured at fair value on recurring basis
Schedule of inventories
Schedule of property and equipment
Schedule of intangible assets
Estimated future amortization expense of intangible assets
Future minimum rental payments
Schedule of future minimum lease payments
Loss per common share
Summary of warrants outstanding
Summary of information about terms of the outstanding warrants
Schedule of assumptions used for fair value of stock options
Option activity
Options outstanding
Schedule of segment information
Schedule of reconciliation of the company's consolidated segment incomed loss
Summary of domestic and foreign components of loss before taxes
Income tax reconciliation
Deferred tax assets and liabilities
Schedule of gained on disposal
Schedule of gained loss calculated
Accumulated deficit
Product and Service [Axis]
Collateral Held [Axis]
Indefinite-Lived Intangible Assets [Axis]
Plan Name [Axis]
Subscriptions [Member]
Automobiles
Intangible Assets
Maximum [Member]
FDIC excess cash balance
Revenues
Advertising expense
Impairment of intangible assets
[Tangible Asset Impairment Charges]
Allowance for credit losses
Estimated useful lives
Fair Value By Fair Value Hierarchy Level Axis
Level 1
Level 2
Level 3
ASSETS
Investment securities - Mutual Funds
Private Credit Funds
[Private Credit Funds]
Total
[Assets, Fair Value Disclosure]
Information By Category Of Debt Security Axis
Mutual Funds
Private Credit Funds
[Private Credit Funds 1]
Cost
Fair value
Unrealized holding gain (loss)
Purchases
Sales
Issuances
Settlements
Transfers into Level 3
Transfers out of Level 3
Balance of recurring Level 3 assets at December 31
[Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value]
Balance of recurring Level 3 assets at January 1
Raw materials
Finished goods
Total Inventories
Inventories-Current Assets
Inventories- Noncurrent Assets
Property Plant And Equipment By Type Axis
Computer equipment
Machinery and equipment
Furniture and fixtures
Leasehold improvements
Bottom [Member]
Top [Member]
Property and equipment, gross
Less accumulated depreciation and amortization
Property and equipment, net
Useful lives
Depreciation expense
Wrote off fully depreciated assets
Accumulated depreciated
Finite Lived Intangible Assets By Major Class Axis
Customer relationships
Minimum [Member]
Maximum [Member]
[Maximum [Member]]
Non-compete agreements
[Non-compete agreements]
Patents
Technology, trademarks
Trade names
Websites
Sublicense agreements
Non-compete agreements
Total Assets
Trade names
[Trade names]
Cost
[Finite-Lived Intangible Assets, Gross]
USeful Lives
Accumulated amortization
Net
2026
2027
2028
Total
Impairment of intangible assets
Goodwill
Total amortization expense
Line of Credit (Details Narrative)
Award Type Axis
Line Of Credit Facility Axis
December 2022
Demand Line of Credit
Proceeds from borrowings
Oustanding line of credit
Related and Nonrelated Parties [Axis]
Employment Agreements Member
Chief Executive Officer and President [Member]
Consulting Agreement Member
Chairman [Member]
Expiry of agreement term
Related Party Transaction Axis
John Nicols[Member]
Consulting fees
Stock option vested
Stock-Based Compensation
Weighted Average Years
Weighted Average Discount
Total Cash Payment
Total Lease Expense
2026
[Lessee, Operating Lease, Liability, to be Paid, Year One]
2027
[Lessee, Operating Lease, Liability, to be Paid, Year Two]
2028
[Lessee, Operating Lease, Liability, to be Paid, Year Three]
Total future minimum payments
Less: imputed interest
[Lessee, Operating Lease, Liability, Undiscounted Excess Amount]
Total present value of operating lease liabilities
Weighted-average discount rate
Weighted average common shares outstanding
Effect of dilutive securities:
Weighted average number of dilutive common shares outstanding
Basic and diluted loss per common share:
Continuing operations
[Continuing operations]
Discontinued operations
[Discontinued operations]
Consolidated operations
[Consolidated operations]
Antidilutive Securities [Axis]
Options And Warrants
Stock Options
[Stock Options]
Warrants
Dilutive shares excluded
Financial Instrument Axis
Warrant
Number of warrant outstanding and exercisable, beginning
[Class of Warrant or Right, Outstanding]
Number of warrant issued
Number of warrants, exercised
Number of warrant expired or cancelled
Number of warrant outstanding and exercisable, ending
Weighted average exercise price exercisable and outstanding, beginning
[Class of Warrant or Right, Exercise Price of Warrants or Rights]
Weighted average exercise price issued
Weighted average exercise price exercised
Weighted average exercise price expired or cancelled
Weighted average exercise price exercisable and outstanding, ending
Weighted average remaining life, beginning
Weighted average remaining life, issued
Weighted average remaining life, expired or cancelled
Weighted Average remaining life, Outstanding and exercisable, ending
Warrant Eight
Warrant Nine
Warrant Ten
Warrant Eleven
Warrant Twelve
Warrant Two
Warrant Three
Warrant Four
Warrant Five
Warrant Six
Warrant Seven
Number of Warrant Outstanding
Weighted Average Exercise Price Outstanding
Warrant Issue Date
Expiration Date
Sale of Stock [Axis]
Class of Warrant or Right [Axis]
Pre Funded Warrants [Member]
2022 Equity Incentive Plan (the "2022 Plan")
2023 Securities Purchase Agreement
Investor [Member]
Private Placement [Member]
Warrants
Warrant description
Warrants remain outstanding
Fair value modification of warrants recorded as stock issuance costs
[Adjustment of Warrants Granted for Services]
Securities purchase agreement, description
Common share authorized capital increase
Proceeds from common stock
Issuence and sold aggregate shares of common stock and warrants
Issuance of shares
Warrants to purchase
Exercise price
Equity issuance cost
Warrant to purchase
Pre-funded warrants
Stock purchased
Legal and placement agent fees
Total consideration
Replacement warrants, outstanding
Expected term (in years)
Risk-free interest rate
Expected volatility
Dividend rate
Vesting Axis
Vested Shares
Non Vested Shares
Number of options outstanding, beginning
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]
Number of options granted
Number of options vested
[Number of options vested]
Number of options forfeited
Number of options outstanding, ending
Number of options exercisable
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]
Weighted average exercise price outstanding, Beginning
[Weighted average exercise price outstanding, Beginning]
Weighted average exercise price granted
Weighted average exercise price vested
Weighted average exercise price exercised
Weighted average exercise price forfeited
Weighted average exercise price outstanding, ending
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]
Weighted average exercise price exercisable
[Weighted average exercise price exercisable]
Weighted average fair value per share of options granted
Aggregate instrinsic value, beginning
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value]
Aggregate instrinsic value, ending
Number of options vested
Weighted average vested price
Weighted Average remaining contractual term
Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range Axis
Exercise Price Range 5.35 - 11.30
Exercise Price Range 2.91 - 4.65
Exercise Price Range 1.29-2.50
Exercise Price Range
Exercise Price Range Three 0.65-2.50
Number of Options Outstanding
Number of Options, Weighted Average remaining contractual term
Number of Options Exercisable
Weighted Average Exercise Price Outstanding, Beginning
Weighted Average Exercise Price Exercisable
Number of Options, Weighted Average remaining contractual term, Excercisable
Title Of Individual Axis
2022 Plan
Mr. Blechman [Member]
Christopher Cox, John Nicols, and Jurgen Schumacher [Member]
Michael Blechman, Christopher Cox, and John Nicols, [Member]
Christopher Cox, and John Nicols, [Member]
Common stock, par value
[Option Contract Indexed to Equity, Settlement, Share, Fair Value Per Share]
Options to purchase
Options previously granted
Noncash stock base compensation expense
Stock options granted
Exercise price
[Exercise price]
Stock compensation expense
Contractual term of the stock options
Stock option vested
[Stock option vested]
Weighted-average period over which the nonvested awards expected to be recognized
Statement Business Segments Axis
Benchtop Laboratory Equipment
Bioprocessing Systems
Corporate and Other
Consolidated
United States revenue
Foreign revenue
Total Revenue
Cost of revenues
Compensation and other personnel expenses
Other expenses
Depreciation and Amortization
Segment Loss From Operations
Assets
Long-Lived Asset Expenditures
Income Tax Authority Name Axis
United State [Member]
All Other Foreign Countries [Member]
Germany [Member]
Long-Lived Assets
Bioprocessing Systems Two [Member]
Loss from Operations
Other income (expense), net
Loss from operations before discontinued operations and income taxes
Customer [Axis]
One Vendor [Member]
Benchtop Laboratory Equipment [Member]
One Customer [Member]
Revenue, percentage
Net purchases, percentage
Bottom [Member]
Top [Member]
Contributions amounted
Employee's deferral over
Employee's deferral
Matching contribution pay over
U.S. operations
Non-U.S. operations
Total loss before taxes
U.S. federal statutory tax rate
U.S. federal statutory tax rate, percent
State income taxes, net of federal income taxeffect
State income taxes, net of federal income taxeffect, percent
Return to provision and other true ups
Return to provision and other true ups, perccent
Foreign tax effects Changes in valuation allowance
Foreign tax effects Changes in valuation allowance, percent
Changes in valuation allowance
[Servicing Asset at Amortized Cost, Increase (Decrease) for Valuation Allowance Adjustment]
Changes in valuation allowance, percent
Changes in valuation allowance
Incentive Stock Options
Incentive Stock Options, percent
Nontaxable or nondeductible Other
Nontaxable or nondeductible Other, percent
Depreciation
Depreciation, percent
Amortization
Amortization, percent
Net Capitalized R&D Expenses
Net Capitalized R&D Expenses, percent
Inventory Reserve
Inventory Reserve, percent
Net Operating Loss
Net Operating Loss, percent
Other
Other, percent
Effective tax rate
Effective tax rate, percent
Federal tax expense
State tax expense
Research and development credits
Incentive stock options
Changes in valuation allowance
[SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction]
Aquila Biolabs GmbH operating loss
Return to provision and other true-ups
Provision for income taxes
Deferred tax assets:
Amortization of intangible assets, including goodwill
Research and development credits
[Deferred Tax Assets, Tax Credit Carryforwards, Research]
Goodwill impairment
Net Capitalized R&D
Various accruals
Stock options expense
Net operating loss
Other
[Deferred Tax Assets, Other]
Subtotal
Deferred tax liability:
Amortization of intangible assets, including goodwill
[Deferred Tax Liabilities, Goodwill and Intangible Assets]
Depreciation
[Depreciation]
Subtotal Deferred Tax Liabilities
Less valuation allowance
[Deferred Tax Assets, Valuation Allowance]
Net deferred tax assets
Federal net operating loss
Foregin net operating loss carryforwards
Provision for income taxes allocated to continuing operations
Provision for income taxes allocated to discontinued operations
Valuation allowance
Operating Activities [Axis]
Discontinued Operations [Member]
Inventory
Fixed Assets
Intangible Assets (Patents)
Net assets
Cash
Less: transaction costs and closing adjustments
Less: Escrow balance to be recognized upon successful transition
Net transaction costs
Gain on disposition
Net Revenue
Cost of Goods Sold
Gross Profit
General and Administrative
Selling
[Selling]
Research and Development
[Research and Development]
Total Expenses
Income from discontinued operations
[Income from discontinued operations]
Current assets of discontinued operations
Business combination consideration transferred
Business combination, contingent consideration arrangement
Business combination, guaranteed portion of contingent consideration
Earned amount
Liabilities of discontinued operations